- Open Access
Evaluation of the depth of sedation in an intensive care unit based on the photo motor reflex variations measured by video pupillometry
© Rouche et al; licensee Springer. 2013
- Received: 29 August 2012
- Accepted: 4 January 2013
- Published: 22 February 2013
Evaluating depth of sedation in the intensive care unit (ICU) is crucial for the management of mechanically ventilated patients but can be challenging in some situations. Because the depth of hypnosis is correlated with the decrease in photomotor reflex (PMR), we suggest using pupillometric video as an automated, noninvasive, simple, and reproducible technique to evaluate the depth of sedation in ICU patients. We compare the effectiveness of this procedure to the bispectral index (BIS).
Thirty-one patients requiring sedation and ventilation were included in this monocentric, observational study. The posology of hypnotics and morphinics were based on the Richmond Agitation and Sedation Scale (RASS). PMR was measured by the Neurolight® (IDMED) system and BIS value by BIS Vista® (Anandic Medical Systems). RASS, PMR, and BIS were measured three times daily in all patients. Data acquired by pupillometric video included variation in pupillary diameter (ΔPD), latency time (LT), and maximal speed of pupillary constriction (Vmax). These parameters were analyzed after having classified BIS values in three groups (<40 heavy sedation; 40 ≤ BIS ≤ 60 acceptable sedation; >60 light sedation). Exclusion criteria were neurological or ophthalmologic pathologies that could interfere with PMR.
There was a significant difference in Vmax and ΔPD between the BIS < 40 group and 40 ≤ BIS ≤ 60 groups (p < 0.0001 for each) and between the BIS < 40 and BIS > 60 groups (p < 0.0001 for each). There were no significant differences in Vmax and ΔPD between the 40 ≤ BIS ≤ 60 and BIS > 60 groups. There was no correlation between any of the BIS groups and LT.
Vmax and ΔPD seem to be relevant criteria compared with the BIS and the RASS. Pupillometric video monitoring of depth of sedation could be beneficial in ICU patients, especially for those under myorelaxant drugs, where no clinical evaluation of sedation is possible.
- Photomotor reflex
- Video pupillometry
- Bispectral index
Large numbers of patients admitted to the intensive care unit (ICU) are sedated when mechanically ventilated . Evaluating the depth of sedation is a crucial element in the management of these patients. Indeed, when sedation is too deep, it can lead to hemodynamic instability, and when too light, it can cause ventilatory difficulties, accidental extubation, or memorization phenomena. Assessing depth of sedation may be difficult in some situations. For example, in patients with acute respiratory distress syndrome (ARDS), ventilation often is difficult and may require myorelaxant drugs, which make it impossible to evaluate clinically the depth of sedation. In these cases, current practice suggests shortly interrupting the administration of these drugs on a daily basis to evaluate correctly the sedation level of the patient.
To optimize the quality of sedation, several review articles and guidelines have been published that outline recommended management [2–4]. Because the depth of hypnosis is known to be correlated with a decrease in photomotor reflex (PMR) [5–10], it could be beneficial to develop an automated, noninvasive, simple, and reproducible technique to evaluate efficiently the depth of sedation in an ICU based on the pupillary reflex.
Depth of sedation is not commonly monitored by the bispectral index (BIS) in the ICU setting; its use is controversial. Several studies have attempted to validate this device compared with commonly used sedation scales. BIS values suffer from a wide dispersion of values compared with predefined clinical scale scores. The main challenge is the overestimation of BIS values due to electromyographic activity . In deeply sedated patients, values remain widely dispersed but are correlated to clinical sedation scale values (e.g., RASS −5).
The objective of this monocentric observational study was to evaluate the effectiveness of pupillometric video using the Neurolight® (IDmed™) system compared with the Richmond Agitation and Sedation Scale (RASS) [12–14] and the bispectral index (BIS).
Patients hospitalized in the ICU of Reims Champagne-Ardennes University Hospital between 1 June and 31 August 2011 were eligible for inclusion in this study. The ICU has a capacity of 15 beds with a nurse to patient ratio of 1:3. All ICU patients who required heavy sedation to be adapted optimally to mechanical ventilation were included in the study. The study protocol was approved by the ethics committee of our institution. Exclusion criteria included all intrinsic or extrinsic patient factors that could interfere with PMR values, namely: i) use of any of the following drugs: clonidine, tramadol, droperidol, metoclopramide, ketamine, adrenalin, or calcium channel blockers [8, 15, 16]; ii) neurological pathologies (severe head trauma, subarachnoid hemorrhage, stroke, intracerebral hemorrhage, or multiple sclerosis); and iii) ophthalmological pathologies (cataract, conjunctivitis, or high myopia).
PMR was measured with a 320 Lux flash of light using the Neurolight® (IDmed, Marseille, France). Three measurements per day were taken for a 48-hour period. BIS values also were recorded (BIS Vista®, Anandic Medical Systems, Feuerthalen, Switzerland). The data recorded by the pupillometric video comprised: variation of pupillary diameter (ΔPD), latency time (LT), and maximal speed of pupillary constriction (Vmax). These measurements were analyzed after classification of BIS values into three groups (<40 heavy sedation; 40 ≤ BIS ≤ 60 acceptable sedation; >60 light sedation) . All assessments of PMR, BIS, and RASS followed a standardized protocol for the study. Each patient had three evaluations per day, at predefined hours and under equivalent lighting conditions. The same physician performed all measurements (O.R.).
Number of measures needed
Quantitative variables are presented as mean ± standard deviation (SD) and qualitative variables as number and percentage. After having verified that the distribution was normal, we conducted repeated measures analysis of variance (ANOVA) for the variables of interest (i.e., ΔPD, LT, Vmax). If repeated measures ANOVA was significant, we considered each measure independently and performed one-way ANOVA adjusted for the subject, day, and measure to compare pupillometry parameters between the three BIS groups. When a significant difference was found, two by two comparisons between the three groups of BIS was performed using Bonferroni tests.
For all analysis, p < 0.05 was considered statistically significant. Analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC).
Baseline characteristics of the study population
All patients (n = 31)
57 ± 14
81.7 ± 18.4
166 ± 32
56.3 ± 15.8
194 ± 114
−4.45 ± 0.71
Death in ICU
Indications for ICU entry
Cardio circulatory arrest
Acute severe asthma
Average doses used for sedation and medications taken by the study population during the study period
Imipenem - cilastatin sodium
Adjusted means of pupillometric measures (Vmax, LT, and ΔPD) for each BIS group
BIS < 40
40 ≤ BIS ≤ 60
BIS > 60
(N = 68)
(N = 62)
(N = 37)
Our results show that depth of sedation seems to be efficiently evaluated by the PMR measured by the Neurolight®. The PMR was correlated to the RASS objectives. Compared with the BIS groups, a significant difference was found between the groups BIS < 40 and 40 ≤ BIS ≤ 60, and between the BIS < 40 and BIS > 60. We could not show a difference between the groups 40 ≤ BIS ≤ 60 and BIS > 60, probably because of the limitations of the BIS use in ICU and perhaps because we did not have enough measurements.
Other studies showed similar interest in the PMR for the evaluation of the sedation. These studies did not concern ICU patients; however, they all showed that the LT variable was probably of no interest in the evaluation of sedation [18, 19].
This device appears to be of utility in the ICU, where patients can often be treated by myorelaxant drugs (muscle-blocking drugs do not alter the PMR ), because no clinical scale can be used in this situation. The utility of the BIS in the ICU remains to be defined , but it is undoubtedly still useful when clinical scales are ineffective, especially when muscular relaxant drugs are used [21–28]. Actually, there is no “gold standard” for evaluating the sedation status in patients under myorelaxant drugs.
Current guidelines recommend interruption of myorelaxant infusion and clinical evaluation of the sedation level when the muscle blockade has been reversed. However, these guidelines can sometimes be difficult to implement, due to the very unstable status of this category of critically ill patients.
The Neurolight® manufacturer (IDmed™) gives an indication of the pupil reactivity (very good, good, week, null) using all three variables measured by the device. To the best of our knowledge, no thresholds have been defined for pupillometry through a large-scale, randomized, controlled trial yet. We only considered the raw results of Vmax, ΔPD, and LT, and therefore, did not take into consideration the pupillary reactivity indicator calculated by the Neurolight®.
Vmax and ΔPD seem to be useful for the evaluation of the sedation in ICU compared with the BIS. This noninvasive technique of monitoring the depth of sedation can be highly beneficial especially for patients under myorelaxant drugs due to the impossibility of using any clinical sedation scales and the fact that these drugs do not alter PMR. This equipment could help reduce the risk of overdose or under dose of hypnotics in the ICU. A larger study is necessary to confirm these results and define cutoff values.
- Payen JF, Chanques G, Mantz J, Hercule C, Auriant I, Leguillou JL: Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiol 2007,106(4):687–695. quiz 891–2 10.1097/01.anes.0000264747.09017.daView ArticleGoogle Scholar
- Sessler CN, Grap MJ, Brophy GM: Multidisciplinary management of sedation and analgesia in critical care. Semin Respir Crit Care Med 2001,22(2):211–226. 10.1055/s-2001-13834View ArticlePubMedGoogle Scholar
- Park G, Coursin D, Ely EW, England M, Fraser GL, Mantz J: Commentary, Balancing sedation and analgesia in the critically ill. Crit Care Clin 2001,17(4):1015–1027. 10.1016/S0749-0704(05)70192-5View ArticlePubMedGoogle Scholar
- French Society of Anesthesiology: Recommendations for sedation, analgesia and curarization. Short text. Societe Francaise d'Anesthesie et de Reanimation. Ann Fr Anesth Reanim 2000,19(5):fi98-fi105.Google Scholar
- Leslie K, Sessler DI, Smith WD, Larson MD, Ozaki M, Blanchard D: Prediction of movement during propofol/nitrous oxide anesthesia. Performance of concentration, electroencephalographic, pupillary, and hemodynamic indicators. Anesthesiol 1996,84(1):52–63. 10.1097/00000542-199601000-00006View ArticleGoogle Scholar
- Larson MD, Kurz A, Sessler DI, Dechert M, Bjorksten AR, Tayefeh F: Alfentanil blocks reflex pupillary dilation in response to noxious stimulation but does not diminish the light reflex. Anesthesiol 1997,87(4):849–855. 10.1097/00000542-199710000-00019View ArticleGoogle Scholar
- Belani KG, Sessler DI, Larson MD, Lopez MA, Washington DE, Ozaki M: The pupillary light reflex, Effects of anesthetics and hyperthermia. Anesthesiol 1993,79(1):23–27. 10.1097/00000542-199307000-00006View ArticleGoogle Scholar
- Knaggs RD, Crighton IM, Cobby TF, Fletcher AJ, Hobbs GJ: The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers. Anesth Analg 2004,99(1):108–112. 10.1213/01.ANE.0000116924.16535.BAView ArticlePubMedGoogle Scholar
- Murray RB, Adler MW, Korczyn AD: The pupillary effects of opioids. Life Sci 1983,33(6):495–509. 10.1016/0024-3205(83)90123-6View ArticlePubMedGoogle Scholar
- Larson MD: Mechanism of opioid-induced pupillary effects. Clin Neurophysiol 2008,119(6):1358–1364. 10.1016/j.clinph.2008.01.106View ArticlePubMedGoogle Scholar
- Vivien B, Di Maria S, Ouattara A, Langeron O, Coriat P, Riou B: Overestimation of Bispectral index in sedated intensive care unit patients revealed by administration of muscle relaxant. Anesthesiol 2003,99(1):9–17. 10.1097/00000542-200307000-00006View ArticleGoogle Scholar
- Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O'Neal PV, Keane KA: The Richmond Agitation-sedation scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002,166(10):1338–1344. 10.1164/rccm.2107138View ArticlePubMedGoogle Scholar
- Chanques G, Jaber S, Barbotte E, Verdier R, Henriette K, Lefrant JY: Validation of the french translated Richmond vigilance-agitation scale. Ann Fr Anesth Reanim 2006,25(7):696–701. 10.1016/j.annfar.2006.02.017View ArticlePubMedGoogle Scholar
- Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S: Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003,289(22):2983–2991. 10.1001/jama.289.22.2983View ArticlePubMedGoogle Scholar
- Larson MD, Talke PO: Effect of dexmedetomidine, an alpha2-adrenoceptor agonist, on human pupillary reflexes during general anaesthesia. Br J Clin Pharmacol 2001,51(1):27–33.PubMed CentralView ArticlePubMedGoogle Scholar
- Eilers H, Larson MD: The effect of ketamine and nitrous oxide on the human pupillary light reflex during general anesthesia. Auton Neurosci 2010,152(1–2):108–114.View ArticlePubMedGoogle Scholar
- Johansen JW, Sebel PS: Development and clinical application of electroencephalographic bispectrum monitoring. Anesthesiol 2000,93(5):1336–1344. 10.1097/00000542-200011000-00029View ArticleGoogle Scholar
- Dereu D, Lukaszewicz AC, Bart F SFAR. Prédiction par la pupillométrie du besoin d'anagésie lors de pansements chirurgicaux chez les patients sédatés de réanimation 2010.Google Scholar
- Delsuc C, Calderon , Portran P SFAR. Pupillométrie et anesthésie 2010.Google Scholar
- Gray AT, Krejci ST, Larson MD: Neuromuscular blocking drugs do not alter the pupillary light reflex of anesthetized humans. Arch Neurol 1997,54(5):579–584. 10.1001/archneur.1997.00550170055014View ArticlePubMedGoogle Scholar
- Thuong M: Sedation and analgesia assessment tools in ICU patients. Ann Fr Anesth Reanim 2008,27(7–8):581–595.View ArticlePubMedGoogle Scholar
- Turkmen A, Altan A, Turgut N, Vatansever S, Gokkaya S: The correlation between the Richmond agitation-sedation scale and bispectral index during dexmedetomidine sedation. Eur J Anaesthesiol 2006,23(4):300–304. 10.1017/S0265021506000081View ArticlePubMedGoogle Scholar
- Brocas E, Dupont H, Paugam-Burtz C, Servin F, Mantz J, Desmonts JM: Bispectral index variations during tracheal suction in mechanically ventilated critically ill patients: effect of an alfentanil bolus. Intensive Care Med 2002,28(2):211–213. 10.1007/s00134-001-1189-yView ArticlePubMedGoogle Scholar
- Deogaonkar A, Gupta R, DeGeorgia M, Sabharwal V, Gopakumaran B, Schubert A: Bispectral Index monitoring correlates with sedation scales in brain-injured patients. Crit Care Med 2004,32(12):2403–2406. 10.1097/01.CCM.0000147442.14921.A5View ArticlePubMedGoogle Scholar
- Consales G, Chelazzi C, Rinaldi S, De Gaudio AR: Bispectral index compared to Ramsay score for sedation monitoring in intensive care units. Minerva Anestesiol 2006,72(5):329–336.PubMedGoogle Scholar
- Frenzel D, Greim CA, Sommer C, Bauerle K, Roewer N: Is the bispectral index appropriate for monitoring the sedation level of mechanically ventilated surgical ICU patients? Intensive Care Med 2002,28(2):178–183. 10.1007/s00134-001-1183-4View ArticlePubMedGoogle Scholar
- Nasraway SS Jr, Wu EC, Kelleher RM, Yasuda CM, Donnelly AM: How reliable is the Bispectral Index in critically ill patients? a prospective, comparative, single-blinded observer study. Crit Care Med 2002,30(7):1483–1487. 10.1097/00003246-200207000-00014View ArticleGoogle Scholar
- Riess ML, Graefe UA, Goeters C, Van Aken H, Bone HG: Sedation assessment in critically ill patients with bispectral index. Eur J Anaesthesiol 2002,19(1):18–22.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.